United Therapeutics: Don't Fear The Patent Expiration Too Much
United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...
Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
Zacks Investment Research on MSN3d
United Therapeutics (UTHR) Down 4.8% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Le Lézard3d
PANTHERx® Rare Selected by Soleno Therapeutics for the Distribution of VYKATtm XR
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Soleno Therapeutics as the specialty pharmacy ...
Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
This Is Reno4d
Pharmacy benefit managers lining pockets at expense of patients, say lawmakers
Lobbyist Danny Thompson, representing the Pharmaceutical Industry Labor and Management Association (PILMA), said PBMs in ...